As of May 27, 2025, Eagle Pharmaceuticals Inc (EGRX) reports a Forward P/E of 0.45.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Eagle Pharmaceuticals Inc's Forward P/E to Peers
To better understand Eagle Pharmaceuticals Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Eagle Pharmaceuticals Inc (EGRX) | 0.45 |
| MeiraGTx Holdings PLC (MGTX) | 206.31 |
| Theratechnologies Inc (TH.TO) | 77.87 |
| MiMedx Group Inc (MDXG) | 26.42 |
| Vertex Pharmaceuticals Inc (VRTX) | 23.87 |
| MannKind Corp (MNKD) | 22.44 |
Compared to its competitors, Eagle Pharmaceuticals Inc's Forward P/E is lower than all peers, which may suggest undervaluation or market concerns about future earnings.